nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—peripheral nervous system neoplasm—brain cancer	0.739	1	CtDrD
Alitretinoin—CYP1A2—Carmustine—brain cancer	0.0157	0.643	CbGbCtD
Alitretinoin—CRABP2—pineal body—brain cancer	0.00478	0.0844	CbGeAlD
Alitretinoin—CYP1A2—Etoposide—brain cancer	0.00464	0.191	CbGbCtD
Alitretinoin—ABCB1—Etoposide—brain cancer	0.00406	0.167	CbGbCtD
Alitretinoin—RXRA—ganglion—brain cancer	0.00342	0.0603	CbGeAlD
Alitretinoin—CRABP2—Pyruvate metabolism—BSG—brain cancer	0.00317	0.064	CbGpPWpGaD
Alitretinoin—CRABP1—Pyruvate metabolism—BSG—brain cancer	0.00317	0.064	CbGpPWpGaD
Alitretinoin—CRABP1—hindbrain—brain cancer	0.00288	0.0508	CbGeAlD
Alitretinoin—CRABP1—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.00192	0.0387	CbGpPWpGaD
Alitretinoin—CRABP2—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.00192	0.0387	CbGpPWpGaD
Alitretinoin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00191	0.0385	CbGpPWpGaD
Alitretinoin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00171	0.0345	CbGpPWpGaD
Alitretinoin—CRABP1—brainstem—brain cancer	0.00165	0.0291	CbGeAlD
Alitretinoin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00164	0.0331	CbGpPWpGaD
Alitretinoin—RXRA—telencephalon—brain cancer	0.00132	0.0233	CbGeAlD
Alitretinoin—CRABP1—gonad—brain cancer	0.00122	0.0216	CbGeAlD
Alitretinoin—CRABP1—pituitary gland—brain cancer	0.00119	0.021	CbGeAlD
Alitretinoin—CRABP1—medulla oblongata—brain cancer	0.00115	0.0203	CbGeAlD
Alitretinoin—CRABP2—gonad—brain cancer	0.00111	0.0195	CbGeAlD
Alitretinoin—RXRB—telencephalon—brain cancer	0.00109	0.0192	CbGeAlD
Alitretinoin—CRABP2—pituitary gland—brain cancer	0.00108	0.019	CbGeAlD
Alitretinoin—CRABP1—midbrain—brain cancer	0.00105	0.0185	CbGeAlD
Alitretinoin—CRABP2—medulla oblongata—brain cancer	0.00104	0.0184	CbGeAlD
Alitretinoin—CRABP1—spinal cord—brain cancer	0.00103	0.0181	CbGeAlD
Alitretinoin—RXRA—Pyruvate metabolism—BSG—brain cancer	0.000961	0.0194	CbGpPWpGaD
Alitretinoin—RXRG—pituitary gland—brain cancer	0.000942	0.0166	CbGeAlD
Alitretinoin—CRABP2—spinal cord—brain cancer	0.000928	0.0164	CbGeAlD
Alitretinoin—CRABP1—endocrine gland—brain cancer	0.000923	0.0163	CbGeAlD
Alitretinoin—CRABP1—head—brain cancer	0.000912	0.0161	CbGeAlD
Alitretinoin—RXRG—medulla oblongata—brain cancer	0.000909	0.016	CbGeAlD
Alitretinoin—RARA—telencephalon—brain cancer	0.000908	0.016	CbGeAlD
Alitretinoin—RXRA—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000898	0.0181	CbGpPWpGaD
Alitretinoin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000868	0.0175	CbGpPWpGaD
Alitretinoin—CRABP2—endocrine gland—brain cancer	0.000835	0.0147	CbGeAlD
Alitretinoin—CRABP1—central nervous system—brain cancer	0.000832	0.0147	CbGeAlD
Alitretinoin—RXRA—endocrine gland—brain cancer	0.000831	0.0147	CbGeAlD
Alitretinoin—RXRG—midbrain—brain cancer	0.000831	0.0147	CbGeAlD
Alitretinoin—CRABP2—head—brain cancer	0.000824	0.0145	CbGeAlD
Alitretinoin—RXRA—head—brain cancer	0.000821	0.0145	CbGeAlD
Alitretinoin—CRABP1—cerebellum—brain cancer	0.000813	0.0143	CbGeAlD
Alitretinoin—RXRG—spinal cord—brain cancer	0.000811	0.0143	CbGeAlD
Alitretinoin—RARG—Nuclear Receptors—ESR2—brain cancer	0.000807	0.0163	CbGpPWpGaD
Alitretinoin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00079	0.0159	CbGpPWpGaD
Alitretinoin—RARA—gonad—brain cancer	0.000758	0.0134	CbGeAlD
Alitretinoin—CRABP2—central nervous system—brain cancer	0.000753	0.0133	CbGeAlD
Alitretinoin—RXRA—central nervous system—brain cancer	0.000749	0.0132	CbGeAlD
Alitretinoin—RARB—endocrine gland—brain cancer	0.000747	0.0132	CbGeAlD
Alitretinoin—CRABP2—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.000744	0.015	CbGpPWpGaD
Alitretinoin—CRABP1—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.000744	0.015	CbGpPWpGaD
Alitretinoin—RARA—pituitary gland—brain cancer	0.000739	0.013	CbGeAlD
Alitretinoin—RXRG—Nuclear Receptors—ESR2—brain cancer	0.000738	0.0149	CbGpPWpGaD
Alitretinoin—RARB—head—brain cancer	0.000737	0.013	CbGeAlD
Alitretinoin—CRABP2—cerebellum—brain cancer	0.000736	0.013	CbGeAlD
Alitretinoin—RXRG—endocrine gland—brain cancer	0.00073	0.0129	CbGeAlD
Alitretinoin—RARB—Nuclear Receptors—ESR2—brain cancer	0.000724	0.0146	CbGpPWpGaD
Alitretinoin—RXRG—head—brain cancer	0.000721	0.0127	CbGeAlD
Alitretinoin—Tretinoin—CYP2C9—brain cancer	0.000713	1	CrCbGaD
Alitretinoin—RARA—Nuclear Receptors—ESR2—brain cancer	0.000694	0.014	CbGpPWpGaD
Alitretinoin—RXRB—Nuclear Receptors—ESR2—brain cancer	0.000694	0.014	CbGpPWpGaD
Alitretinoin—RXRB—endocrine gland—brain cancer	0.000686	0.0121	CbGeAlD
Alitretinoin—RXRB—head—brain cancer	0.000678	0.012	CbGeAlD
Alitretinoin—CRABP1—brain—brain cancer	0.000661	0.0117	CbGeAlD
Alitretinoin—RARB—cerebellum—brain cancer	0.000658	0.0116	CbGeAlD
Alitretinoin—RXRG—central nervous system—brain cancer	0.000658	0.0116	CbGeAlD
Alitretinoin—RARG—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000638	0.0129	CbGpPWpGaD
Alitretinoin—RXRB—central nervous system—brain cancer	0.000618	0.0109	CbGeAlD
Alitretinoin—RXRB—cerebellum—brain cancer	0.000604	0.0107	CbGeAlD
Alitretinoin—RARG—head—brain cancer	0.000601	0.0106	CbGeAlD
Alitretinoin—CRABP2—brain—brain cancer	0.000597	0.0105	CbGeAlD
Alitretinoin—RXRA—brain—brain cancer	0.000595	0.0105	CbGeAlD
Alitretinoin—RXRG—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000583	0.0118	CbGpPWpGaD
Alitretinoin—RXRA—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.000581	0.0117	CbGpPWpGaD
Alitretinoin—RARA—endocrine gland—brain cancer	0.000573	0.0101	CbGeAlD
Alitretinoin—RARB—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000572	0.0115	CbGpPWpGaD
Alitretinoin—RARA—head—brain cancer	0.000565	0.00998	CbGeAlD
Alitretinoin—RARG—central nervous system—brain cancer	0.000549	0.00969	CbGeAlD
Alitretinoin—RXRB—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000549	0.0111	CbGpPWpGaD
Alitretinoin—RARA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000549	0.0111	CbGpPWpGaD
Alitretinoin—RXRA—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000543	0.0109	CbGpPWpGaD
Alitretinoin—RARG—cerebellum—brain cancer	0.000537	0.00947	CbGeAlD
Alitretinoin—RARB—brain—brain cancer	0.000534	0.00943	CbGeAlD
Alitretinoin—RXRG—brain—brain cancer	0.000522	0.00921	CbGeAlD
Alitretinoin—RARA—central nervous system—brain cancer	0.000516	0.00911	CbGeAlD
Alitretinoin—RARA—cerebellum—brain cancer	0.000505	0.0089	CbGeAlD
Alitretinoin—RXRB—brain—brain cancer	0.000491	0.00866	CbGeAlD
Alitretinoin—RXRG—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000456	0.00918	CbGpPWpGaD
Alitretinoin—RXRA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00044	0.00887	CbGpPWpGaD
Alitretinoin—RARG—brain—brain cancer	0.000436	0.00769	CbGeAlD
Alitretinoin—RXRB—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000428	0.00863	CbGpPWpGaD
Alitretinoin—RXRA—Orphan transporters—S100A10—brain cancer	0.000422	0.0085	CbGpPWpGaD
Alitretinoin—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000417	0.00841	CbGpPWpGaD
Alitretinoin—RARA—brain—brain cancer	0.00041	0.00723	CbGeAlD
Alitretinoin—RXRA—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000409	0.00824	CbGpPWpGaD
Alitretinoin—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000401	0.00808	CbGpPWpGaD
Alitretinoin—RXRA—Transcription factor regulation in adipogenesis—IRS2—brain cancer	0.000364	0.00733	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptors—ESR2—brain cancer	0.000362	0.00729	CbGpPWpGaD
Alitretinoin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000359	0.00723	CbGpPWpGaD
Alitretinoin—ABCB1—blood vessel—brain cancer	0.000356	0.00627	CbGeAlD
Alitretinoin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000342	0.00689	CbGpPWpGaD
Alitretinoin—RXRA—PPAR Alpha Pathway—CDK4—brain cancer	0.000298	0.00602	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000297	0.00598	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000297	0.00598	CbGpPWpGaD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.000287	0.00579	CbGpPWpGaD
Alitretinoin—RXRA—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000286	0.00576	CbGpPWpGaD
Alitretinoin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000273	0.0055	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.00027	0.00544	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000249	0.00501	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000238	0.00481	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000236	0.00475	CbGpPWpGaD
Alitretinoin—RXRA—Biological oxidations—CYP2C9—brain cancer	0.000234	0.00471	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000226	0.00456	CbGpPWpGaD
Alitretinoin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.000225	0.00454	CbGpPWpGaD
Alitretinoin—RXRA—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000223	0.0045	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000217	0.00437	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000217	0.00437	CbGpPWpGaD
Alitretinoin—CYP1A2—endocrine gland—brain cancer	0.000212	0.00375	CbGeAlD
Alitretinoin—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.0002	0.00404	CbGpPWpGaD
Alitretinoin—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.000199	0.00401	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000199	0.00401	CbGpPWpGaD
Alitretinoin—RXRA—PPAR Alpha Pathway—CCND1—brain cancer	0.000193	0.00389	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000191	0.00384	CbGpPWpGaD
Alitretinoin—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	0.000187	0.00377	CbGpPWpGaD
Alitretinoin—RXRG—Adipogenesis—IRS2—brain cancer	0.000179	0.00361	CbGpPWpGaD
Alitretinoin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000173	0.00349	CbGpPWpGaD
Alitretinoin—ABCB1—telencephalon—brain cancer	0.000173	0.00304	CbGeAlD
Alitretinoin—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000171	0.00344	CbGpPWpGaD
Alitretinoin—RARA—Adipogenesis—IRS2—brain cancer	0.000168	0.0034	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000163	0.00329	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00016	0.00323	CbGpPWpGaD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000158	0.00319	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000157	0.00316	CbGpPWpGaD
Alitretinoin—RXRA—PPAR Alpha Pathway—MYC—brain cancer	0.000155	0.00312	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000154	0.0031	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000152	0.00306	CbGpPWpGaD
Alitretinoin—Hypotension—Procarbazine—brain cancer	0.000148	0.00114	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000147	0.00297	CbGpPWpGaD
Alitretinoin—Neuropathy peripheral—Temozolomide—brain cancer	0.000147	0.00114	CcSEcCtD
Alitretinoin—Stomatitis—Temozolomide—brain cancer	0.000146	0.00113	CcSEcCtD
Alitretinoin—Urinary tract infection—Temozolomide—brain cancer	0.000146	0.00113	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000144	0.00112	CcSEcCtD
Alitretinoin—ABCB1—gonad—brain cancer	0.000144	0.00254	CbGeAlD
Alitretinoin—Insomnia—Procarbazine—brain cancer	0.000143	0.00111	CcSEcCtD
Alitretinoin—Paraesthesia—Procarbazine—brain cancer	0.000142	0.0011	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000141	0.00284	CbGpPWpGaD
Alitretinoin—Sinusitis—Temozolomide—brain cancer	0.000141	0.00109	CcSEcCtD
Alitretinoin—Somnolence—Procarbazine—brain cancer	0.000141	0.00109	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—brain cancer	0.000141	0.00284	CbGpPWpGaD
Alitretinoin—ABCB1—pituitary gland—brain cancer	0.00014	0.00248	CbGeAlD
Alitretinoin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00014	0.00283	CbGpPWpGaD
Alitretinoin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00014	0.00109	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.00014	0.00283	CbGpPWpGaD
Alitretinoin—Haemoglobin—Carmustine—brain cancer	0.00014	0.00108	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.00014	0.00282	CbGpPWpGaD
Alitretinoin—Haemorrhage—Carmustine—brain cancer	0.000139	0.00108	CcSEcCtD
Alitretinoin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000139	0.00108	CcSEcCtD
Alitretinoin—Anaemia—Hydroxyurea—brain cancer	0.000139	0.00107	CcSEcCtD
Alitretinoin—Hypoaesthesia—Carmustine—brain cancer	0.000139	0.00107	CcSEcCtD
Alitretinoin—Hallucination—Carmustine—brain cancer	0.000139	0.00107	CcSEcCtD
Alitretinoin—Decreased appetite—Procarbazine—brain cancer	0.000138	0.00106	CcSEcCtD
Alitretinoin—Oedema peripheral—Carmustine—brain cancer	0.000137	0.00106	CcSEcCtD
Alitretinoin—Fatigue—Procarbazine—brain cancer	0.000136	0.00106	CcSEcCtD
Alitretinoin—ABCB1—medulla oblongata—brain cancer	0.000136	0.00239	CbGeAlD
Alitretinoin—Haemoglobin—Temozolomide—brain cancer	0.000135	0.00105	CcSEcCtD
Alitretinoin—Malaise—Hydroxyurea—brain cancer	0.000135	0.00105	CcSEcCtD
Alitretinoin—Pain—Procarbazine—brain cancer	0.000135	0.00105	CcSEcCtD
Alitretinoin—Constipation—Procarbazine—brain cancer	0.000135	0.00105	CcSEcCtD
Alitretinoin—Haemorrhage—Temozolomide—brain cancer	0.000135	0.00104	CcSEcCtD
Alitretinoin—Hepatitis—Temozolomide—brain cancer	0.000135	0.00104	CcSEcCtD
Alitretinoin—Dysphagia—Etoposide—brain cancer	0.000135	0.00104	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000134	0.00271	CbGpPWpGaD
Alitretinoin—Visual impairment—Carmustine—brain cancer	0.000134	0.00104	CcSEcCtD
Alitretinoin—Hypoaesthesia—Temozolomide—brain cancer	0.000134	0.00104	CcSEcCtD
Alitretinoin—Hallucination—Temozolomide—brain cancer	0.000134	0.00104	CcSEcCtD
Alitretinoin—Pharyngitis—Temozolomide—brain cancer	0.000134	0.00103	CcSEcCtD
Alitretinoin—Urinary tract disorder—Temozolomide—brain cancer	0.000133	0.00103	CcSEcCtD
Alitretinoin—Oedema peripheral—Temozolomide—brain cancer	0.000133	0.00103	CcSEcCtD
Alitretinoin—Bronchospasm—Etoposide—brain cancer	0.000132	0.00102	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—CYP2C9—brain cancer	0.000132	0.00266	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—CYP2C9—brain cancer	0.000132	0.00266	CbGpPWpGaD
Alitretinoin—Urethral disorder—Temozolomide—brain cancer	0.000132	0.00102	CcSEcCtD
Alitretinoin—Sweating increased—Etoposide—brain cancer	0.000131	0.00101	CcSEcCtD
Alitretinoin—Feeling abnormal—Procarbazine—brain cancer	0.00013	0.00101	CcSEcCtD
Alitretinoin—Eye disorder—Carmustine—brain cancer	0.00013	0.00101	CcSEcCtD
Alitretinoin—Convulsion—Hydroxyurea—brain cancer	0.00013	0.00101	CcSEcCtD
Alitretinoin—Visual impairment—Temozolomide—brain cancer	0.00013	0.001	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Procarbazine—brain cancer	0.000129	0.001	CcSEcCtD
Alitretinoin—Flushing—Carmustine—brain cancer	0.000129	0.001	CcSEcCtD
Alitretinoin—Erythema multiforme—Temozolomide—brain cancer	0.000127	0.000985	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000127	0.000982	CcSEcCtD
Alitretinoin—Discomfort—Hydroxyurea—brain cancer	0.000126	0.000977	CcSEcCtD
Alitretinoin—Neutropenia—Etoposide—brain cancer	0.000126	0.000974	CcSEcCtD
Alitretinoin—Eye disorder—Temozolomide—brain cancer	0.000126	0.000974	CcSEcCtD
Alitretinoin—Urticaria—Procarbazine—brain cancer	0.000126	0.000973	CcSEcCtD
Alitretinoin—Tinnitus—Temozolomide—brain cancer	0.000126	0.000971	CcSEcCtD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.000125	0.00252	CbGpPWpGaD
Alitretinoin—Abdominal pain—Procarbazine—brain cancer	0.000125	0.000968	CcSEcCtD
Alitretinoin—Body temperature increased—Procarbazine—brain cancer	0.000125	0.000968	CcSEcCtD
Alitretinoin—Flushing—Temozolomide—brain cancer	0.000125	0.000967	CcSEcCtD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000125	0.00251	CbGpPWpGaD
Alitretinoin—Arrhythmia—Carmustine—brain cancer	0.000124	0.000963	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000124	0.0025	CbGpPWpGaD
Alitretinoin—ABCB1—midbrain—brain cancer	0.000124	0.00219	CbGeAlD
Alitretinoin—Alopecia—Carmustine—brain cancer	0.000123	0.000953	CcSEcCtD
Alitretinoin—Oedema—Hydroxyurea—brain cancer	0.000122	0.000948	CcSEcCtD
Alitretinoin—Angiopathy—Temozolomide—brain cancer	0.000122	0.000945	CcSEcCtD
Alitretinoin—Mental disorder—Carmustine—brain cancer	0.000122	0.000945	CcSEcCtD
Alitretinoin—Infection—Hydroxyurea—brain cancer	0.000122	0.000941	CcSEcCtD
Alitretinoin—Erythema—Carmustine—brain cancer	0.000121	0.000939	CcSEcCtD
Alitretinoin—Malnutrition—Carmustine—brain cancer	0.000121	0.000939	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000121	0.00244	CbGpPWpGaD
Alitretinoin—ABCB1—spinal cord—brain cancer	0.000121	0.00213	CbGeAlD
Alitretinoin—Chills—Temozolomide—brain cancer	0.000121	0.000935	CcSEcCtD
Alitretinoin—Pneumonia—Etoposide—brain cancer	0.000121	0.000934	CcSEcCtD
Alitretinoin—Nervous system disorder—Hydroxyurea—brain cancer	0.00012	0.000929	CcSEcCtD
Alitretinoin—Infestation—Etoposide—brain cancer	0.00012	0.000929	CcSEcCtD
Alitretinoin—Infestation NOS—Etoposide—brain cancer	0.00012	0.000929	CcSEcCtD
Alitretinoin—Thrombocytopenia—Hydroxyurea—brain cancer	0.00012	0.000928	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000119	0.000921	CcSEcCtD
Alitretinoin—Alopecia—Temozolomide—brain cancer	0.000119	0.000921	CcSEcCtD
Alitretinoin—Skin disorder—Hydroxyurea—brain cancer	0.000119	0.00092	CcSEcCtD
Alitretinoin—Acute coronary syndrome—Etoposide—brain cancer	0.000118	0.000916	CcSEcCtD
Alitretinoin—Renal failure—Etoposide—brain cancer	0.000118	0.000913	CcSEcCtD
Alitretinoin—Mental disorder—Temozolomide—brain cancer	0.000118	0.000913	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000118	0.00237	CbGpPWpGaD
Alitretinoin—Myocardial infarction—Etoposide—brain cancer	0.000118	0.00091	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Etoposide—brain cancer	0.000118	0.00091	CcSEcCtD
Alitretinoin—Back pain—Carmustine—brain cancer	0.000117	0.000908	CcSEcCtD
Alitretinoin—Malnutrition—Temozolomide—brain cancer	0.000117	0.000907	CcSEcCtD
Alitretinoin—Erythema—Temozolomide—brain cancer	0.000117	0.000907	CcSEcCtD
Alitretinoin—Stomatitis—Etoposide—brain cancer	0.000117	0.000905	CcSEcCtD
Alitretinoin—Anorexia—Hydroxyurea—brain cancer	0.000117	0.000903	CcSEcCtD
Alitretinoin—Hypersensitivity—Procarbazine—brain cancer	0.000117	0.000902	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000116	0.00234	CbGpPWpGaD
Alitretinoin—Vision blurred—Carmustine—brain cancer	0.000114	0.000885	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000114	0.0023	CbGpPWpGaD
Alitretinoin—Tremor—Carmustine—brain cancer	0.000114	0.000879	CcSEcCtD
Alitretinoin—Asthenia—Procarbazine—brain cancer	0.000114	0.000878	CcSEcCtD
Alitretinoin—Back pain—Temozolomide—brain cancer	0.000113	0.000877	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—BSG—brain cancer	0.000112	0.00226	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—BSG—brain cancer	0.000112	0.00226	CbGpPWpGaD
Alitretinoin—Anaemia—Carmustine—brain cancer	0.000112	0.000867	CcSEcCtD
Alitretinoin—Agranulocytosis—Etoposide—brain cancer	0.000112	0.000867	CcSEcCtD
Alitretinoin—Pruritus—Procarbazine—brain cancer	0.000112	0.000866	CcSEcCtD
Alitretinoin—Agitation—Carmustine—brain cancer	0.000111	0.000863	CcSEcCtD
Alitretinoin—Vision blurred—Temozolomide—brain cancer	0.00011	0.000855	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—ESR2—brain cancer	0.00011	0.00222	CbGpPWpGaD
Alitretinoin—Tremor—Temozolomide—brain cancer	0.00011	0.00085	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000109	0.0022	CbGpPWpGaD
Alitretinoin—Dyspnoea—Hydroxyurea—brain cancer	0.000109	0.000845	CcSEcCtD
Alitretinoin—Somnolence—Hydroxyurea—brain cancer	0.000109	0.000842	CcSEcCtD
Alitretinoin—ABCB1—endocrine gland—brain cancer	0.000109	0.00192	CbGeAlD
Alitretinoin—Ill-defined disorder—Temozolomide—brain cancer	0.000109	0.000842	CcSEcCtD
Alitretinoin—Anaemia—Temozolomide—brain cancer	0.000108	0.000838	CcSEcCtD
Alitretinoin—Diarrhoea—Procarbazine—brain cancer	0.000108	0.000838	CcSEcCtD
Alitretinoin—Dyspepsia—Hydroxyurea—brain cancer	0.000108	0.000834	CcSEcCtD
Alitretinoin—Agitation—Temozolomide—brain cancer	0.000108	0.000834	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—CTNNB1—brain cancer	0.000107	0.00217	CbGpPWpGaD
Alitretinoin—ABCB1—head—brain cancer	0.000107	0.0019	CbGeAlD
Alitretinoin—Hypoaesthesia—Etoposide—brain cancer	0.000107	0.00083	CcSEcCtD
Alitretinoin—Decreased appetite—Hydroxyurea—brain cancer	0.000106	0.000824	CcSEcCtD
Alitretinoin—Urinary tract disorder—Etoposide—brain cancer	0.000106	0.000823	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000106	0.000818	CcSEcCtD
Alitretinoin—Malaise—Temozolomide—brain cancer	0.000106	0.000818	CcSEcCtD
Alitretinoin—Urethral disorder—Etoposide—brain cancer	0.000106	0.000817	CcSEcCtD
Alitretinoin—Fatigue—Hydroxyurea—brain cancer	0.000106	0.000817	CcSEcCtD
Alitretinoin—Convulsion—Carmustine—brain cancer	0.000105	0.000813	CcSEcCtD
Alitretinoin—Hypertension—Carmustine—brain cancer	0.000105	0.00081	CcSEcCtD
Alitretinoin—Constipation—Hydroxyurea—brain cancer	0.000105	0.00081	CcSEcCtD
Alitretinoin—Pain—Hydroxyurea—brain cancer	0.000105	0.00081	CcSEcCtD
Alitretinoin—Dizziness—Procarbazine—brain cancer	0.000105	0.00081	CcSEcCtD
Alitretinoin—RARG—Generic Transcription Pathway—NOTCH2—brain cancer	0.000104	0.0021	CbGpPWpGaD
Alitretinoin—Palpitations—Temozolomide—brain cancer	0.000104	0.000802	CcSEcCtD
Alitretinoin—Chest pain—Carmustine—brain cancer	0.000103	0.000799	CcSEcCtD
Alitretinoin—Myalgia—Carmustine—brain cancer	0.000103	0.000799	CcSEcCtD
Alitretinoin—RXRA—Transmembrane transport of small molecules—S100A10—brain cancer	0.000103	0.00208	CbGpPWpGaD
Alitretinoin—Anxiety—Carmustine—brain cancer	0.000103	0.000796	CcSEcCtD
Alitretinoin—Cough—Temozolomide—brain cancer	0.000102	0.000791	CcSEcCtD
Alitretinoin—Erythema multiforme—Etoposide—brain cancer	0.000102	0.000788	CcSEcCtD
Alitretinoin—Convulsion—Temozolomide—brain cancer	0.000102	0.000786	CcSEcCtD
Alitretinoin—Hypertension—Temozolomide—brain cancer	0.000101	0.000783	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—CTNNB1—brain cancer	0.000101	0.00204	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Hydroxyurea—brain cancer	0.000101	0.000781	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—ESR2—brain cancer	0.000101	0.00203	CbGpPWpGaD
Alitretinoin—Eye disorder—Etoposide—brain cancer	0.000101	0.000779	CcSEcCtD
Alitretinoin—Vomiting—Procarbazine—brain cancer	0.000101	0.000778	CcSEcCtD
Alitretinoin—Flushing—Etoposide—brain cancer	0.0001	0.000774	CcSEcCtD
Alitretinoin—Confusional state—Carmustine—brain cancer	9.98e-05	0.000772	CcSEcCtD
Alitretinoin—Myalgia—Temozolomide—brain cancer	9.98e-05	0.000772	CcSEcCtD
Alitretinoin—Arthralgia—Temozolomide—brain cancer	9.98e-05	0.000772	CcSEcCtD
Alitretinoin—Rash—Procarbazine—brain cancer	9.98e-05	0.000772	CcSEcCtD
Alitretinoin—Dermatitis—Procarbazine—brain cancer	9.97e-05	0.000771	CcSEcCtD
Alitretinoin—Anxiety—Temozolomide—brain cancer	9.95e-05	0.00077	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	9.94e-05	0.002	CbGpPWpGaD
Alitretinoin—Headache—Procarbazine—brain cancer	9.91e-05	0.000767	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	9.91e-05	0.000767	CcSEcCtD
Alitretinoin—Oedema—Carmustine—brain cancer	9.9e-05	0.000766	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—ESR2—brain cancer	9.88e-05	0.00199	CbGpPWpGaD
Alitretinoin—Discomfort—Temozolomide—brain cancer	9.86e-05	0.000763	CcSEcCtD
Alitretinoin—Infection—Carmustine—brain cancer	9.84e-05	0.000761	CcSEcCtD
Alitretinoin—ABCB1—central nervous system—brain cancer	9.81e-05	0.00173	CbGeAlD
Alitretinoin—Angiopathy—Etoposide—brain cancer	9.78e-05	0.000756	CcSEcCtD
Alitretinoin—Dry mouth—Temozolomide—brain cancer	9.76e-05	0.000755	CcSEcCtD
Alitretinoin—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—brain cancer	9.75e-05	0.00197	CbGpPWpGaD
Alitretinoin—Thrombocytopenia—Carmustine—brain cancer	9.69e-05	0.00075	CcSEcCtD
Alitretinoin—Body temperature increased—Hydroxyurea—brain cancer	9.68e-05	0.000749	CcSEcCtD
Alitretinoin—Chills—Etoposide—brain cancer	9.67e-05	0.000748	CcSEcCtD
Alitretinoin—Tachycardia—Carmustine—brain cancer	9.66e-05	0.000748	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—IDH1—brain cancer	9.66e-05	0.00195	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—IDH1—brain cancer	9.66e-05	0.00195	CbGpPWpGaD
Alitretinoin—Confusional state—Temozolomide—brain cancer	9.65e-05	0.000746	CcSEcCtD
Alitretinoin—ABCB1—cerebellum—brain cancer	9.58e-05	0.00169	CbGeAlD
Alitretinoin—Anaphylactic shock—Temozolomide—brain cancer	9.57e-05	0.00074	CcSEcCtD
Alitretinoin—Oedema—Temozolomide—brain cancer	9.57e-05	0.00074	CcSEcCtD
Alitretinoin—RXRG—Generic Transcription Pathway—NOTCH2—brain cancer	9.55e-05	0.00192	CbGpPWpGaD
Alitretinoin—Alopecia—Etoposide—brain cancer	9.52e-05	0.000737	CcSEcCtD
Alitretinoin—Infection—Temozolomide—brain cancer	9.51e-05	0.000735	CcSEcCtD
Alitretinoin—RXRB—Generic Transcription Pathway—ESR2—brain cancer	9.48e-05	0.00191	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—ESR2—brain cancer	9.48e-05	0.00191	CbGpPWpGaD
Alitretinoin—Anorexia—Carmustine—brain cancer	9.44e-05	0.00073	CcSEcCtD
Alitretinoin—Nausea—Procarbazine—brain cancer	9.4e-05	0.000727	CcSEcCtD
Alitretinoin—Nervous system disorder—Temozolomide—brain cancer	9.38e-05	0.000726	CcSEcCtD
Alitretinoin—RXRG—Adipogenesis—STAT3—brain cancer	9.37e-05	0.00189	CbGpPWpGaD
Alitretinoin—Thrombocytopenia—Temozolomide—brain cancer	9.37e-05	0.000725	CcSEcCtD
Alitretinoin—RARB—Generic Transcription Pathway—NOTCH2—brain cancer	9.36e-05	0.00189	CbGpPWpGaD
Alitretinoin—Skin disorder—Temozolomide—brain cancer	9.29e-05	0.000719	CcSEcCtD
Alitretinoin—Hypotension—Carmustine—brain cancer	9.25e-05	0.000716	CcSEcCtD
Alitretinoin—Hyperhidrosis—Temozolomide—brain cancer	9.25e-05	0.000716	CcSEcCtD
Alitretinoin—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	9.24e-05	0.00186	CbGpPWpGaD
Alitretinoin—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	9.21e-05	0.00186	CbGpPWpGaD
Alitretinoin—Anorexia—Temozolomide—brain cancer	9.12e-05	0.000706	CcSEcCtD
Alitretinoin—Back pain—Etoposide—brain cancer	9.07e-05	0.000702	CcSEcCtD
Alitretinoin—Hypersensitivity—Hydroxyurea—brain cancer	9.02e-05	0.000698	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Carmustine—brain cancer	9.02e-05	0.000698	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.98e-05	0.00181	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—NOTCH2—brain cancer	8.97e-05	0.00181	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—NOTCH2—brain cancer	8.97e-05	0.00181	CbGpPWpGaD
Alitretinoin—Insomnia—Carmustine—brain cancer	8.96e-05	0.000693	CcSEcCtD
Alitretinoin—Paraesthesia—Carmustine—brain cancer	8.89e-05	0.000688	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	8.86e-05	0.00179	CbGpPWpGaD
Alitretinoin—Dyspnoea—Carmustine—brain cancer	8.83e-05	0.000683	CcSEcCtD
Alitretinoin—RARA—Adipogenesis—STAT3—brain cancer	8.81e-05	0.00178	CbGpPWpGaD
Alitretinoin—Somnolence—Carmustine—brain cancer	8.8e-05	0.000681	CcSEcCtD
Alitretinoin—Asthenia—Hydroxyurea—brain cancer	8.79e-05	0.00068	CcSEcCtD
Alitretinoin—RXRA—Adipogenesis—IRS2—brain cancer	8.78e-05	0.00177	CbGpPWpGaD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	8.72e-05	0.00176	CbGpPWpGaD
Alitretinoin—Musculoskeletal discomfort—Temozolomide—brain cancer	8.72e-05	0.000674	CcSEcCtD
Alitretinoin—Ill-defined disorder—Etoposide—brain cancer	8.7e-05	0.000673	CcSEcCtD
Alitretinoin—Anaemia—Etoposide—brain cancer	8.67e-05	0.000671	CcSEcCtD
Alitretinoin—Insomnia—Temozolomide—brain cancer	8.65e-05	0.00067	CcSEcCtD
Alitretinoin—Decreased appetite—Carmustine—brain cancer	8.61e-05	0.000666	CcSEcCtD
Alitretinoin—Paraesthesia—Temozolomide—brain cancer	8.59e-05	0.000665	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Carmustine—brain cancer	8.55e-05	0.000661	CcSEcCtD
Alitretinoin—Dyspnoea—Temozolomide—brain cancer	8.53e-05	0.00066	CcSEcCtD
Alitretinoin—Somnolence—Temozolomide—brain cancer	8.51e-05	0.000658	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	8.49e-05	0.00171	CbGpPWpGaD
Alitretinoin—Pain—Carmustine—brain cancer	8.47e-05	0.000655	CcSEcCtD
Alitretinoin—Constipation—Carmustine—brain cancer	8.47e-05	0.000655	CcSEcCtD
Alitretinoin—Malaise—Etoposide—brain cancer	8.46e-05	0.000655	CcSEcCtD
Alitretinoin—Dyspepsia—Temozolomide—brain cancer	8.42e-05	0.000652	CcSEcCtD
Alitretinoin—Diarrhoea—Hydroxyurea—brain cancer	8.38e-05	0.000648	CcSEcCtD
Alitretinoin—Decreased appetite—Temozolomide—brain cancer	8.32e-05	0.000643	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Temozolomide—brain cancer	8.26e-05	0.000639	CcSEcCtD
Alitretinoin—Fatigue—Temozolomide—brain cancer	8.25e-05	0.000638	CcSEcCtD
Alitretinoin—Loss of consciousness—Etoposide—brain cancer	8.25e-05	0.000638	CcSEcCtD
Alitretinoin—Cough—Etoposide—brain cancer	8.19e-05	0.000633	CcSEcCtD
Alitretinoin—Pain—Temozolomide—brain cancer	8.18e-05	0.000633	CcSEcCtD
Alitretinoin—Constipation—Temozolomide—brain cancer	8.18e-05	0.000633	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	8.16e-05	0.00165	CbGpPWpGaD
Alitretinoin—Feeling abnormal—Carmustine—brain cancer	8.16e-05	0.000631	CcSEcCtD
Alitretinoin—Convulsion—Etoposide—brain cancer	8.13e-05	0.000629	CcSEcCtD
Alitretinoin—Hypertension—Etoposide—brain cancer	8.1e-05	0.000627	CcSEcCtD
Alitretinoin—Dizziness—Hydroxyurea—brain cancer	8.1e-05	0.000627	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Carmustine—brain cancer	8.1e-05	0.000626	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	8.01e-05	0.00161	CbGpPWpGaD
Alitretinoin—Chest pain—Etoposide—brain cancer	7.99e-05	0.000618	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	7.93e-05	0.000614	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	7.91e-05	0.00159	CbGpPWpGaD
Alitretinoin—Discomfort—Etoposide—brain cancer	7.89e-05	0.00061	CcSEcCtD
Alitretinoin—Feeling abnormal—Temozolomide—brain cancer	7.88e-05	0.00061	CcSEcCtD
Alitretinoin—CRABP2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.86e-05	0.00158	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.86e-05	0.00158	CbGpPWpGaD
Alitretinoin—Body temperature increased—Carmustine—brain cancer	7.83e-05	0.000606	CcSEcCtD
Alitretinoin—Abdominal pain—Carmustine—brain cancer	7.83e-05	0.000606	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.83e-05	0.00158	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Temozolomide—brain cancer	7.82e-05	0.000605	CcSEcCtD
Alitretinoin—Vomiting—Hydroxyurea—brain cancer	7.79e-05	0.000602	CcSEcCtD
Alitretinoin—ABCB1—brain—brain cancer	7.78e-05	0.00137	CbGeAlD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	7.75e-05	0.00156	CbGpPWpGaD
Alitretinoin—Rash—Hydroxyurea—brain cancer	7.72e-05	0.000597	CcSEcCtD
Alitretinoin—Confusional state—Etoposide—brain cancer	7.72e-05	0.000597	CcSEcCtD
Alitretinoin—Dermatitis—Hydroxyurea—brain cancer	7.72e-05	0.000597	CcSEcCtD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.69e-05	0.00155	CbGpPWpGaD
Alitretinoin—Headache—Hydroxyurea—brain cancer	7.67e-05	0.000594	CcSEcCtD
Alitretinoin—Anaphylactic shock—Etoposide—brain cancer	7.66e-05	0.000592	CcSEcCtD
Alitretinoin—CRABP2—Metabolism—ENO2—brain cancer	7.63e-05	0.00154	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ENO2—brain cancer	7.63e-05	0.00154	CbGpPWpGaD
Alitretinoin—Infection—Etoposide—brain cancer	7.61e-05	0.000588	CcSEcCtD
Alitretinoin—Urticaria—Temozolomide—brain cancer	7.6e-05	0.000588	CcSEcCtD
Alitretinoin—Body temperature increased—Temozolomide—brain cancer	7.56e-05	0.000585	CcSEcCtD
Alitretinoin—Abdominal pain—Temozolomide—brain cancer	7.56e-05	0.000585	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	7.5e-05	0.00151	CbGpPWpGaD
Alitretinoin—Thrombocytopenia—Etoposide—brain cancer	7.5e-05	0.00058	CcSEcCtD
Alitretinoin—Tachycardia—Etoposide—brain cancer	7.47e-05	0.000578	CcSEcCtD
Alitretinoin—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.46e-05	0.0015	CbGpPWpGaD
Alitretinoin—Skin disorder—Etoposide—brain cancer	7.44e-05	0.000575	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	7.43e-05	0.0015	CbGpPWpGaD
Alitretinoin—Hyperhidrosis—Etoposide—brain cancer	7.4e-05	0.000573	CcSEcCtD
Alitretinoin—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.36e-05	0.00148	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	7.35e-05	0.00148	CbGpPWpGaD
Alitretinoin—Anorexia—Etoposide—brain cancer	7.3e-05	0.000565	CcSEcCtD
Alitretinoin—Hypersensitivity—Carmustine—brain cancer	7.29e-05	0.000564	CcSEcCtD
Alitretinoin—Nausea—Hydroxyurea—brain cancer	7.28e-05	0.000563	CcSEcCtD
Alitretinoin—Hypotension—Etoposide—brain cancer	7.15e-05	0.000553	CcSEcCtD
Alitretinoin—Asthenia—Carmustine—brain cancer	7.1e-05	0.00055	CcSEcCtD
Alitretinoin—Hypersensitivity—Temozolomide—brain cancer	7.05e-05	0.000545	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	7e-05	0.00141	CbGpPWpGaD
Alitretinoin—Paraesthesia—Etoposide—brain cancer	6.88e-05	0.000532	CcSEcCtD
Alitretinoin—Asthenia—Temozolomide—brain cancer	6.86e-05	0.000531	CcSEcCtD
Alitretinoin—Dyspnoea—Etoposide—brain cancer	6.83e-05	0.000528	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.82e-05	0.00138	CbGpPWpGaD
Alitretinoin—Somnolence—Etoposide—brain cancer	6.81e-05	0.000527	CcSEcCtD
Alitretinoin—Diarrhoea—Carmustine—brain cancer	6.77e-05	0.000524	CcSEcCtD
Alitretinoin—Pruritus—Temozolomide—brain cancer	6.77e-05	0.000524	CcSEcCtD
Alitretinoin—Decreased appetite—Etoposide—brain cancer	6.66e-05	0.000515	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Etoposide—brain cancer	6.61e-05	0.000511	CcSEcCtD
Alitretinoin—Fatigue—Etoposide—brain cancer	6.6e-05	0.000511	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.56e-05	0.00132	CbGpPWpGaD
Alitretinoin—Dizziness—Carmustine—brain cancer	6.55e-05	0.000507	CcSEcCtD
Alitretinoin—Constipation—Etoposide—brain cancer	6.55e-05	0.000507	CcSEcCtD
Alitretinoin—Pain—Etoposide—brain cancer	6.55e-05	0.000507	CcSEcCtD
Alitretinoin—Diarrhoea—Temozolomide—brain cancer	6.55e-05	0.000506	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	6.54e-05	0.00132	CbGpPWpGaD
Alitretinoin—Dizziness—Temozolomide—brain cancer	6.33e-05	0.00049	CcSEcCtD
Alitretinoin—Feeling abnormal—Etoposide—brain cancer	6.31e-05	0.000488	CcSEcCtD
Alitretinoin—Vomiting—Carmustine—brain cancer	6.3e-05	0.000487	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.28e-05	0.00127	CbGpPWpGaD
Alitretinoin—Gastrointestinal pain—Etoposide—brain cancer	6.26e-05	0.000484	CcSEcCtD
Alitretinoin—Rash—Carmustine—brain cancer	6.24e-05	0.000483	CcSEcCtD
Alitretinoin—Dermatitis—Carmustine—brain cancer	6.24e-05	0.000483	CcSEcCtD
Alitretinoin—Headache—Carmustine—brain cancer	6.2e-05	0.00048	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.14e-05	0.00124	CbGpPWpGaD
Alitretinoin—Vomiting—Temozolomide—brain cancer	6.08e-05	0.000471	CcSEcCtD
Alitretinoin—Urticaria—Etoposide—brain cancer	6.08e-05	0.000471	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	6.05e-05	0.00122	CbGpPWpGaD
Alitretinoin—Body temperature increased—Etoposide—brain cancer	6.05e-05	0.000468	CcSEcCtD
Alitretinoin—Abdominal pain—Etoposide—brain cancer	6.05e-05	0.000468	CcSEcCtD
Alitretinoin—Rash—Temozolomide—brain cancer	6.03e-05	0.000467	CcSEcCtD
Alitretinoin—Dermatitis—Temozolomide—brain cancer	6.03e-05	0.000466	CcSEcCtD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.02e-05	0.00121	CbGpPWpGaD
Alitretinoin—Headache—Temozolomide—brain cancer	5.99e-05	0.000464	CcSEcCtD
Alitretinoin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	5.95e-05	0.0012	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—DNMT1—brain cancer	5.91e-05	0.00119	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.89e-05	0.00119	CbGpPWpGaD
Alitretinoin—Nausea—Carmustine—brain cancer	5.88e-05	0.000455	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—brain cancer	5.7e-05	0.00115	CbGpPWpGaD
Alitretinoin—Nausea—Temozolomide—brain cancer	5.68e-05	0.00044	CcSEcCtD
Alitretinoin—Hypersensitivity—Etoposide—brain cancer	5.64e-05	0.000436	CcSEcCtD
Alitretinoin—RXRA—Developmental Biology—TRPC6—brain cancer	5.6e-05	0.00113	CbGpPWpGaD
Alitretinoin—Asthenia—Etoposide—brain cancer	5.49e-05	0.000425	CcSEcCtD
Alitretinoin—Pruritus—Etoposide—brain cancer	5.42e-05	0.000419	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—DNMT1—brain cancer	5.41e-05	0.00109	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—ESR2—brain cancer	5.31e-05	0.00107	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—DNMT1—brain cancer	5.3e-05	0.00107	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—CTNNB1—brain cancer	5.27e-05	0.00106	CbGpPWpGaD
Alitretinoin—Diarrhoea—Etoposide—brain cancer	5.24e-05	0.000405	CcSEcCtD
Alitretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.15e-05	0.00104	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—DNMT1—brain cancer	5.08e-05	0.00102	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—DNMT1—brain cancer	5.08e-05	0.00102	CbGpPWpGaD
Alitretinoin—Dizziness—Etoposide—brain cancer	5.06e-05	0.000392	CcSEcCtD
Alitretinoin—RARG—Gene Expression—NOTCH2—brain cancer	5.02e-05	0.00101	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	4.97e-05	0.001	CbGpPWpGaD
Alitretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.94e-05	0.000996	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—ESR2—brain cancer	4.94e-05	0.000995	CbGpPWpGaD
Alitretinoin—Vomiting—Etoposide—brain cancer	4.87e-05	0.000377	CcSEcCtD
Alitretinoin—RXRG—Gene Expression—ESR2—brain cancer	4.85e-05	0.000978	CbGpPWpGaD
Alitretinoin—Rash—Etoposide—brain cancer	4.83e-05	0.000373	CcSEcCtD
Alitretinoin—Dermatitis—Etoposide—brain cancer	4.82e-05	0.000373	CcSEcCtD
Alitretinoin—Headache—Etoposide—brain cancer	4.8e-05	0.000371	CcSEcCtD
Alitretinoin—RARB—Gene Expression—ESR2—brain cancer	4.76e-05	0.000959	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—TRPC6—brain cancer	4.76e-05	0.000959	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.71e-05	0.000949	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NOTCH2—brain cancer	4.68e-05	0.000943	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NOTCH2—brain cancer	4.6e-05	0.000926	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—STAT3—brain cancer	4.59e-05	0.000925	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—ESR2—brain cancer	4.56e-05	0.00092	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—ESR2—brain cancer	4.56e-05	0.00092	CbGpPWpGaD
Alitretinoin—Nausea—Etoposide—brain cancer	4.55e-05	0.000352	CcSEcCtD
Alitretinoin—RARB—Gene Expression—NOTCH2—brain cancer	4.51e-05	0.000908	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.44e-05	0.000894	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	4.43e-05	0.000892	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NOTCH2—brain cancer	4.32e-05	0.000871	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NOTCH2—brain cancer	4.32e-05	0.000871	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—SIRT1—brain cancer	4.27e-05	0.000861	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.12e-05	0.00083	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2C9—brain cancer	4e-05	0.000806	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4e-05	0.000806	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.97e-05	0.000801	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.91e-05	0.000788	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SIRT1—brain cancer	3.91e-05	0.000788	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.87e-05	0.00078	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SIRT1—brain cancer	3.83e-05	0.000772	CbGpPWpGaD
Alitretinoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.72e-05	0.00075	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SIRT1—brain cancer	3.67e-05	0.000741	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SIRT1—brain cancer	3.67e-05	0.000741	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HES1—brain cancer	3.61e-05	0.000728	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CG—brain cancer	3.5e-05	0.000706	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CG—brain cancer	3.5e-05	0.000706	CbGpPWpGaD
Alitretinoin—RARG—Generic Transcription Pathway—MYC—brain cancer	3.48e-05	0.000701	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	3.41e-05	0.000687	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—BSG—brain cancer	3.4e-05	0.000685	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.4e-05	0.000685	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.26e-05	0.000658	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—IL2—brain cancer	3.25e-05	0.000655	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.2e-05	0.000645	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.19e-05	0.000642	CbGpPWpGaD
Alitretinoin—RXRG—Generic Transcription Pathway—MYC—brain cancer	3.18e-05	0.000641	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.16e-05	0.000637	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.14e-05	0.000632	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.12e-05	0.00063	CbGpPWpGaD
Alitretinoin—RARB—Generic Transcription Pathway—MYC—brain cancer	3.12e-05	0.000628	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.07e-05	0.000618	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.06e-05	0.000616	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.06e-05	0.000616	CbGpPWpGaD
Alitretinoin—RARA—Generic Transcription Pathway—MYC—brain cancer	2.99e-05	0.000603	CbGpPWpGaD
Alitretinoin—RXRB—Generic Transcription Pathway—MYC—brain cancer	2.99e-05	0.000603	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.94e-05	0.000592	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—IDH1—brain cancer	2.92e-05	0.000589	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.86e-05	0.000577	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CDK4—brain cancer	2.83e-05	0.000571	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.8e-05	0.000564	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.76e-05	0.000556	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—DNMT1—brain cancer	2.65e-05	0.000534	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.58e-05	0.000519	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.42e-05	0.000488	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.38e-05	0.00048	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ESR2—brain cancer	2.38e-05	0.000479	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ENO2—brain cancer	2.31e-05	0.000466	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.28e-05	0.000459	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NOTCH2—brain cancer	2.25e-05	0.000454	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.09e-05	0.000422	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RELA—brain cancer	2.08e-05	0.00042	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ERBB2—brain cancer	2.07e-05	0.000417	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SIRT1—brain cancer	1.91e-05	0.000386	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.9e-05	0.000383	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CTNNB1—brain cancer	1.81e-05	0.000365	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.77e-05	0.000356	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—brain cancer	1.67e-05	0.000337	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2C9—brain cancer	1.6e-05	0.000322	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—brain cancer	1.59e-05	0.000321	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—brain cancer	1.58e-05	0.000318	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.56e-05	0.000315	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—brain cancer	1.56e-05	0.000314	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.55e-05	0.000312	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—brain cancer	1.53e-05	0.000309	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—brain cancer	1.5e-05	0.000303	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—brain cancer	1.44e-05	0.00029	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—brain cancer	1.44e-05	0.00029	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—brain cancer	1.43e-05	0.000289	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.36e-05	0.000275	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—BSG—brain cancer	1.36e-05	0.000274	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2C9—brain cancer	1.28e-05	0.000257	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.25e-05	0.000253	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.23e-05	0.000247	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—IDH1—brain cancer	1.17e-05	0.000235	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—BSG—brain cancer	1.08e-05	0.000219	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CG—brain cancer	1.06e-05	0.000214	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.03e-05	0.000207	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—IDH1—brain cancer	9.32e-06	0.000188	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ENO2—brain cancer	9.23e-06	0.000186	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.59e-06	0.000153	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—brain cancer	7.5e-06	0.000151	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ENO2—brain cancer	7.37e-06	0.000149	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CG—brain cancer	4.24e-06	8.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CG—brain cancer	3.38e-06	6.82e-05	CbGpPWpGaD
